Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.

Lignende værker

• Adaptive dosing and platinum–DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours
  af: Veal, G J, et al.
  Udgivet: (2007)
• Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.
  af: English, M. W., et al.
  Udgivet: (1996)
• Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin and Other Platinum Complexes
  af: Hall, Matthew D., et al.
  Udgivet: (2014)
• Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours.
  af: Schellens, J. H., et al.
  Udgivet: (1996)
• Randomized cross-over clinical trial to study potential pharmacokinetic interactions between cisplatin or carboplatin and etoposide
  af: Thomas, Huw D, et al.
  Udgivet: (2002)